ACTIVATE: A phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with Pyruvate kinase deficiency who are not regularly transfused - Al-Samkari, H; Galacteros, F; Glenthoj, A; Rothman, J A; Andres, O; Grace, R F; Arias, Morado M; Layton, D M; Onodera, K; Verhovsek, M; Barcellini, W; Judge, M P; et al. (ONCOLOGY RESEARCH AND TREATMENT, 2021)